Considering HBV progression, the levels of IL-1β, IL-17, IL-10, IP-10, MCP-1, and MIP-1β were all markedly decreased in the hepatoma group compared to that in the CHB group (Table 2, Figure 1). This evidence concerns the gene CCL4 and hepatocellular carcinoma.